Search
Search Results
##search.searchResults.foundPlural##
-
Major Artery Occlusion: a Rare Complication of Sickle Cell Disease
1360PDF: 1035HTML: 4603 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3687PDF: 1236HTML: 3889Untitled: 212Untitled: 259 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3148PDF: 1138HTML: 1484Untitled: 176Untitled: 165Untitled: 167 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3235PDF: 908HTML: 758text and figure: 227 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2016PDF: 758HTML: 3113 -
-
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1538PDF: 785HTML: 1476Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 179 -
-
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2121PDF: 759HTML: 1044Spirometry in SCA patients before transplant: 200Spirometry in SCA patients post transplant: 180 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2133PDF: 1275Html: 283 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1321PDF: 1128HTML: 119 -
-
Sickle cell disease and Bartonella spp. infection
1163PDF: 867HTML: 455 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
695PDF: 529HTML: 212 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2271PDF: 933HTML: 302 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1614PDF: 990HTML: 358 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1063PDF: 961HTML: 327 -
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1107PDF: 485HTML: 8164 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2409PDF: 1590HTML: 626 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2099PDF: 486HTML: 129 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
996PDF: 988Suppl. Files: 636HTML: 127 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7959PDF: 4131HTML: 7365 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2185PDF: 1168HTML: 2588Study of serum haptoglobin level in thalassemia: 343Figures: 176 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
876PDF: 685HTML: 320 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3384PDF: 1292HTML: 1862Fig.1: 199Fig. 2: 207







